We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 370.24%
This Fund
S&P 500
This Quarter Est. Return
+13.41%
1 Year Est. Return
+370.24%
3 Year Est. Return
+1,243.07%
5 Year Est. Return
+867.54%
10 Year Est. Return
+12,575.88%
AUM
$144M
AUM Growth
-$27.9M
Cap. Flow
-$36M
Cap. Flow %
-24.94%
Top 10 Hldgs %
91.04%
Holding
68
New
13
Increased
10
Reduced
2
Closed
37

Top Buys

Rank Stock Value
1
BBBY
Bed Bath & Beyond
BBBY
+$6.75M
2
OGEN icon
Oragenics
OGEN
+$2.61M
3
AGX icon
Argan
AGX
+$2.27M
4
TRNX
Taronis Technologies, Inc. Common Stock
TRNX
+$1.99M
5
TOON icon
Kartoon Studios
TOON
+$1.23M

Top Sells

Rank Stock Value
1
TLRY icon
Tilray
TLRY
+$99.4M
2
OTRK
Ontrak
OTRK
+$1.13M
3
CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
+$987K
4
IRD
Opus Genetics
IRD
+$565K
5
VLRX
VALERITAS HOLDINGS INC
VLRX
+$563K

Sector Composition

Rank Sector Weight
1 Real Estate 5.79%
2 Consumer Discretionary 4.27%
3 Industrials 3.66%
4 Healthcare 1.82%
5 Energy 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UXIN
51
CALL
Uxin Ltd
UXIN
$339M
– –
-769
Closed -$374K
CSCI
52
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
– –
-3,358
Closed -$987K
IRD
53
Opus Genetics
IRD
$270M
– –
-12,648
Closed -$565K
LUMO
54
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-31,362
Closed -$429K
NTBL
55
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
– –
-1,314
Closed -$45K
TCON
56
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
– –
-1,251
Closed -$158K
SCPX
57
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
-15
Closed -$413K
ONCT
58
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
– –
-1,894
Closed -$207K
INFI
59
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-293,427
Closed -$346K
DTEA
60
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
– –
-326,414
Closed -$385K
VIVE
61
DELISTED
VIVEVE MED INC
VIVE
– –
-250
Closed -$263K
RESN
62
DELISTED
Resonant Inc.
RESN
– –
-210,631
Closed -$280K
TRIL
63
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-174,174
Closed -$298K
FRAN
64
DELISTED
Francesca's Holdings Corporation
FRAN
– –
-25,492
Closed -$297K
TTPH
65
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-16,797
Closed -$380K
FOMX
66
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-79,061
Closed -$284K
VLRX
67
DELISTED
VALERITAS HOLDINGS INC
VLRX
– –
-86,481
Closed -$563K
ONCS
68
DELISTED
OncoSec Medical Incorporated
ONCS
– –
-2,925
Closed -$412K
1 2
3

Similar funds

RA
RPOA Advisors Plano, Texas $2.29B AUM 11.74% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
7WCP
71 West Capital Partners Boston, Massachusetts $2.27B AUM

Anson Funds Management's Q1 2019 Portfolio in Review

As of Q1 2019, Anson Funds Management held 68 positions worth $144M, down 16% from $172M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Anson Funds Management withdrew a net $36M in Q1 2019, closing 37 positions and reducing 2 holdings. Its most notable exit was Tilray, an estimated $99.4M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 5.8% of assets, up from 2.8% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Anson Funds Management opened a new position in Bed Bath & Beyond worth $6.17M.

  • Anson Funds Management's largest Q1 2019 buy was Bed Bath & Beyond: 493,880 shares worth $6.17M.
  • Anson Funds Management added most to Argan in Q1 2019, an estimated $2.27M increase.
  • Anson Funds Management's biggest Q1 2019 reduction was Invitation Homes, cutting an estimated $114K.
  • Anson Funds Management fully exited Tilray in Q1 2019, selling an estimated $99.4M.
  • Anson Funds Management's ten largest holdings make up 91% of its $144M portfolio in Q1 2019.
  • Anson Funds Management opened 13 new positions and closed 37 in Q1 2019.
  • Anson Funds Management's portfolio value fell 16% quarter-over-quarter to $144M.

Based on Anson Funds Management's 13F filing for Q1 2019, filed 15 May 2019.